Nicola DI RENZO, MD

Hematology and SCT Unit, Vito Fazzi Hospital, Italy

Poster(s):

• 1507 - Allogeneic stem cell transplantation is effective after pathway inhibitor treatments in CLL – a retrospective study on behalf of the Chronic Malignancies Working Party of EBMT

• 1709 - Impact of Dose Intensity of Ibrutinib on Clinical Outcomes of CLL Patients: Analysis of the EVIdeNCE Study